MDT

94.99

-0.35%↓

VEEV

292.58

+1.89%↑

A

140.97

+1.06%↑

HQY

90.94

-1.4%↓

TLRY

1.54

-8.33%↓

MDT

94.99

-0.35%↓

VEEV

292.58

+1.89%↑

A

140.97

+1.06%↑

HQY

90.94

-1.4%↓

TLRY

1.54

-8.33%↓

MDT

94.99

-0.35%↓

VEEV

292.58

+1.89%↑

A

140.97

+1.06%↑

HQY

90.94

-1.4%↓

TLRY

1.54

-8.33%↓

MDT

94.99

-0.35%↓

VEEV

292.58

+1.89%↑

A

140.97

+1.06%↑

HQY

90.94

-1.4%↓

TLRY

1.54

-8.33%↓

MDT

94.99

-0.35%↓

VEEV

292.58

+1.89%↑

A

140.97

+1.06%↑

HQY

90.94

-1.4%↓

TLRY

1.54

-8.33%↓

Search

CareDx Inc

Cerrado

SectorSanidad

15 2.04

Resumen

Variación precio

24h

Actual

Mínimo

14.67

Máximo

15.41

Métricas clave

By Trading Economics

Ingresos

1.8M

-8.6M

Ventas

2M

87M

P/B

Media del Sector

13.838

36.442

Margen de beneficios

-9.885

Empleados

644

EBITDA

9.3M

-4M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+15.65% upside

Dividendos

By Dow Jones

Próximas Ganancias

3 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

72M

773M

Apertura anterior

12.96

Cierre anterior

15

Noticias sobre sentimiento de mercado

By Acuity

41%

59%

147 / 371 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Neutral Evidence

CareDx Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

15 oct 2025, 23:25 UTC

Principales Movimientos del Mercado

Salesforce Rises on New FY30 Financial Targets

15 oct 2025, 18:52 UTC

Ganancias
Principales Movimientos del Mercado

Prologis Shares Gain on Raised Outlook, Data Center Growth

15 oct 2025, 18:30 UTC

Adquisiciones, fusiones, absorciones

Constellation Software to Buy U.K.'s Tecvia Holding

15 oct 2025, 17:19 UTC

Adquisiciones, fusiones, absorciones

Drahi's Altice Rejects $20 Billion Joint Offer From Peers -- 2nd Update

15 oct 2025, 17:11 UTC

Adquisiciones, fusiones, absorciones

Anglo American, MMG Offer Concessions to EU Merger Watchdog in Nickel Deal Probe

15 oct 2025, 23:48 UTC

Charlas de Mercado

Gold Steady, Supported by Expectations of Ongoing Central Bank Purchases -- Market Talk

15 oct 2025, 23:38 UTC

Charlas de Mercado

Nikkei May Rise, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

15 oct 2025, 22:37 UTC

Charlas de Mercado

Economic Stars Are Aligning for RBA -- Market Talk

15 oct 2025, 21:44 UTC

Ganancias

Stock Rally Is Lifting Wealth Managers. How Much Is Charles Schwab Benefiting? -- Barrons.com

15 oct 2025, 20:50 UTC

Charlas de Mercado
Ganancias

Financial Services Roundup: Market Talk

15 oct 2025, 20:44 UTC

Adquisiciones, fusiones, absorciones

Restaurant Brands Recommends Hldrs Do Not Tender Their Shrs to the Offer >QSR.T

15 oct 2025, 20:44 UTC

Adquisiciones, fusiones, absorciones

Restaurant Brands Notified of Unsolicited Mini-Tender Offer to Buy Shrs at $28.80/Shr

15 oct 2025, 20:43 UTC

Adquisiciones, fusiones, absorciones

Restaurant Brands Notified of Unsolicited Mini-Tender Offer by NY Stk and Bond LLC to Purchase Up to 10,000 Common Shrs >QSR.T

15 oct 2025, 20:34 UTC

Ganancias

Prologis Raises Outlook as Warehouse Leasing Picks Up -- WSJ

15 oct 2025, 20:31 UTC

Adquisiciones, fusiones, absorciones

RBI Recommends Hldrs Reject NYSB's "Mini-Tender Offer"

15 oct 2025, 20:17 UTC

Adquisiciones, fusiones, absorciones

GE Vernova Stock Feill With Latest Call to Sell -- Barrons.com

15 oct 2025, 19:06 UTC

Ganancias

These Stocks Are Moving the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More -- Barrons.com

15 oct 2025, 19:04 UTC

Charlas de Mercado

Oil Futures Post Back-to-Back Losses -- Market Talk

15 oct 2025, 18:46 UTC

Charlas de Mercado

U.S. Natural Gas Futures Slip Ahead of Storage Data -- Market Talk

15 oct 2025, 18:23 UTC

Ganancias

This Insurer Is the One of the Worst Stocks in the S&P 500 Today. Here's Why. -- Barrons.com

15 oct 2025, 17:37 UTC

Adquisiciones, fusiones, absorciones

Constellation Software's Harris Operating Group Enters Into Agreement To Acquire TECVIA Holding GmbH >CSU.T

15 oct 2025, 17:34 UTC

Charlas de Mercado

Oil Futures Lose Ground on Trade, Oversupply Concerns -- Market Talk

15 oct 2025, 16:57 UTC

Ganancias

The Nation's Biggest Banks Are Saying the Economy Is Still Strong -- WSJ

15 oct 2025, 16:51 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica Doesn't Disclose Financial Details

15 oct 2025, 16:50 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica: RetinAI Partners With Pharmaceutical Companies, Research Organizations

15 oct 2025, 16:49 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica: Deal Reinforces the Group's Med-Tech Journey

15 oct 2025, 16:48 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica: Ikerian Specializes in Artificial Intelligence, Data Management in Eyecare

15 oct 2025, 16:48 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica: Ikerian Is a Health Technology Company, Operating Under the RetinAI Brand

15 oct 2025, 16:47 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica Buys Ikerian

15 oct 2025, 16:34 UTC

Charlas de Mercado

AMD Data Center Agreements Will Provide Big Revenue Growth -- Market Talk

Comparación entre iguales

Cambio de precio

CareDx Inc previsión

Precio Objetivo

By TipRanks

15.65% repunte

Estimación a 12 Meses

Media 17 USD  15.65%

Máximo 22 USD

Mínimo 14 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CareDx Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

7 ratings

2

Comprar

5

Mantener

0

Vender

Puntuación técnica

By Trading Central

14.77 / 18.49Soporte y Resistencia

Corto Plazo

Neutral Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

147 / 371 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
help-icon Live chat